NewDays provides a science-backed cognitive rehabilitation program that combines telehealth appointments with licensed clinicians and frequent engagement with an AI companion called Sunny. Patients use structured, long-form conversations with Sunny to improve verbal fluency, memory, and emotional well-being; clinicians personalize exercises based on interactions. The program is built on evidence from over 300 clinical trials and more than 50 meta-analyses, and NewDays has exclusive access to the I-CONECT study. Early access participants reported high satisfaction, with all surveyed users saying they felt better after completing the full regimen. NewDays currently offers free daily AI exercises to all users and premium plans that include personalized treatment and clinician consultations, many of which are covered by insurance. The company is available in four states (after pilots in California, Washington, and Florida and expansion into Texas) and plans to expand nationwide by the end of the year.

Total raised

$7M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2025